Cargando…

CT103A, a forward step in multiple myeloma immunotherapies

Detalles Bibliográficos
Autores principales: Xu, Jie, Melenhorst, J. Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975015/
https://www.ncbi.nlm.nih.gov/pubmed/35402835
http://dx.doi.org/10.1097/BS9.0000000000000068
_version_ 1784680322772762624
author Xu, Jie
Melenhorst, J. Joseph
author_facet Xu, Jie
Melenhorst, J. Joseph
author_sort Xu, Jie
collection PubMed
description
format Online
Article
Text
id pubmed-8975015
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89750152022-04-07 CT103A, a forward step in multiple myeloma immunotherapies Xu, Jie Melenhorst, J. Joseph Blood Sci Commentary Lippincott Williams & Wilkins 2021-04-27 /pmc/articles/PMC8975015/ /pubmed/35402835 http://dx.doi.org/10.1097/BS9.0000000000000068 Text en Copyright © 2021 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Association for Blood Sciences. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Commentary
Xu, Jie
Melenhorst, J. Joseph
CT103A, a forward step in multiple myeloma immunotherapies
title CT103A, a forward step in multiple myeloma immunotherapies
title_full CT103A, a forward step in multiple myeloma immunotherapies
title_fullStr CT103A, a forward step in multiple myeloma immunotherapies
title_full_unstemmed CT103A, a forward step in multiple myeloma immunotherapies
title_short CT103A, a forward step in multiple myeloma immunotherapies
title_sort ct103a, a forward step in multiple myeloma immunotherapies
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975015/
https://www.ncbi.nlm.nih.gov/pubmed/35402835
http://dx.doi.org/10.1097/BS9.0000000000000068
work_keys_str_mv AT xujie ct103aaforwardstepinmultiplemyelomaimmunotherapies
AT melenhorstjjoseph ct103aaforwardstepinmultiplemyelomaimmunotherapies